CapsoVision, Inc

CV ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $-25.3M $-19.9M
Depreciation & Amortization $216.0K $206.0K
Depreciation
Amortization
Stock-Based Compensation $826.0K $156.0K
Net Cash from Operating Activities $-22.9M $-20.1M
Investing Activities
Capital Expenditures $90.0K $153.0K
Business Acquisitions
Net Cash from Investing Activities $-90.0K $-153.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $23.6M $15.1M
Net Change in Cash
Free Cash Flow $-23.0M $-20.2M